CircoMax Myco

Authorised

This medicine is authorised for use in the European Union

porcine circovirus vaccine (inactivated, recombinant) / mycoplasma hyopneumoniae vaccine (inactivated)

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  CircoMax Myco
• Active substance:
  • Inactivated Mycoplasma hyopneumoniae, strain P-5722-3
  • inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (ORF2) protein
  • inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b ORF2 protein
• International non-proprietary name (INN) or common name:
  • porcine circovirus vaccine (inactivated, recombinant)
  • mycoplasma hyopneumoniae vaccine (inactivated)

Pharmacotherapeutic group

• Immunologicals for suidae
• Inactivated viral and inactivated bacterial vaccines

Authorisation details

• EMA product number:
  EMEA/V/C/005184

Assessment history

Changes since initial authorisation of medicine

CVMP post-authorisation summary of positive opinion for CircoMax Myco

Adopted Reference Number: EMA/CVMP/452705/2023

Initial marketing authorisation documents

CVMP summary of positive opinion for CircoMax Myco

Adopted Reference Number: EMA/CVMP/495892/2020